What is VRNA's gross margin?

Verona Pharma (VRNA) has a gross margin of 95% and a net margin of 12%.

What is VRNA's P/E ratio?

Track Verona Pharma (VRNA) P/E ratio, ROE, and valuation metrics over time.

Where can I see VRNA's full financials?

See Verona Pharma (VRNA) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Verona Pharma (VRNA) Financials — Revenue, Earnings, Cash Flow

$106.91

Last traded 2025-10-06 — delisted

NASDAQ · Healthcare · Biotechnology · $72.7B mcap · 71M float · 5.04% daily turnover · Short 23% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

📊 Key Metrics

TTM

$168M

Revenue

+0.0% YoY

$-63M

Net Income

+36.6% YoY

$-73M

Free Cash Flow

-35.4% YoY

95.4%

Gross Margin

12.9%

Op. Margin

11.6%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-28.3%

ROA-12.5%

ROIC-40.5%

Valuation

P/E-63.6

P/B42.0

EV/EBITDA-205.7

Leverage

Debt/Equity0.88

Current Ratio10.71

Interest Cov.-1.1x

Quality Scores

Piotroski F4/9

Altman Z17.22

Beneish M0.00